Reuters logo
BRIEF-Synergy Pharmaceuticals posts Q3 loss per share $0.22
November 9, 2017 / 9:07 PM / a month ago

BRIEF-Synergy Pharmaceuticals posts Q3 loss per share $0.22

Nov 9 (Reuters) - Synergy Pharmaceuticals Inc

* Synergy Pharmaceuticals reports third quarter 2017 financial results and business update

* Q3 loss per share $0.22

* Q3 sales $5.0 million versus I/B/E/S view $4.5 million

* Q3 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

* Synergy Pharmaceuticals Inc - ‍cash and cash equivalents were about $117.8 million at end of quarter​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below